MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$40,791K
Marketable securities
$14,990K
Prepaid expenses and
other current assets
$2,485K
Accounts receivable
$891K
Total current assets
$59,157K
Intangible assets, net
$31,700K
Goodwill
$10,672K
Deferred tax asset, net
$5,800K
Property and equipment,
net
$2,566K
Operating lease
right-of-use assets
$2,131K
Deposits and other
long-term assets
$558K
Total assets
$112,584K
Total liabilities and
shareholders equity
$112,584K
Total liabilities
$69,238K
Total shareholders
equity
$43,346K
Noncontrolling deficit
-$1,203K
Warrant liabilities
$43,906K
Deferred revenues, net of
current portion
$12,377K
Total current
liabilities
$11,367K
Operating lease
liabilities, net of current...
$1,534K
Finance lease
liabilities, net of current...
$32K
Deferred tax liability,
net
$22K
Lineage's shareholders'
equity
$44,549K
Accumulated deficit
-$466,998K
Accumulated other
comprehensive loss
-$3,920K
Accounts payable and
accrued liabilities
$7,181K
Deferred revenues,
current portion
$3,333K
Operating lease
liabilities, current portion
$816K
Finance lease
liabilities, current portion
$37K
Common shares, no par
value, 450,000 shares...
$515,467K
Back
Back
Balance Sheet
source: myfinsight.com
Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. (LCTX)